Susquehanna International Group, LLP Kamada LTD Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$4.78 - $5.75 $286,322 - $344,425
-59,900 Reduced 59.66%
40,500 $200,000
Q1 2024

May 07, 2024
BUY
$5.58 - $6.42 $403,434 - $464,166
72,300 Added 257.3%
100,400 $563,000
Q4 2023

Feb 14, 2024
BUY
$4.14 - $6.22 $116,333 - $174,782
28,100 New
28,100 $171,000

Others Institutions Holding KMDA

# of Institutions
33
Shares Held
6.48M
Call Options Held
200
Put Options Held
0
View Full List

About KAMADA LTD

KMDA Quotes by TradingView
  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $267M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email